Tag

Dea

All articles tagged with #dea

DEA Expands Probe Into Hayden Panettiere’s Death
entertainment5 days ago

DEA Expands Probe Into Hayden Panettiere’s Death

The Drug Enforcement Administration has joined the Greenville, SC death investigation into actress Hayden Panettiere. Local police say an autopsy has been completed and no trauma was found, but the cause and manner of death remain under investigation with the Greenville Police Department still leading the probe. Panettiere publicly discussed her experiences with child stardom, abuse in Hollywood, postpartum depression, and addiction in her memoir and interviews.

DEA Expands Probe Into Hayden Panettiere’s Death
entertainment6 days ago

DEA Expands Probe Into Hayden Panettiere’s Death

The Drug Enforcement Administration has joined a joint investigation into Hayden Panettiere’s death, alongside Greenville Police Department and the local coroner’s office, with authorities saying the cause of death has not yet been determined. Panettiere, 36, had discussed years of drug and alcohol struggles in her 2026 memoir, and tributes from colleagues followed the news.

DEA Joins Greenville Probe Into Hayden Panettiere’s Death
entertainment6 days ago

DEA Joins Greenville Probe Into Hayden Panettiere’s Death

The Greenville City Police Department is leading the investigation into the death of 36-year-old actress Hayden Panettiere, with the Drug Enforcement Administration assisting. The coroner has not yet determined a cause of death, pending further studies. Investigators reviewed the scene at a private residence in Greenville, where Panettiere’s on-again/off-again boyfriend Brian Hickerson and his brother were present, and officers were shown a bag of Panettiere’s medications. Tributes have poured in from fans and colleagues as the investigation continues.

Barr and Sabet Warn Against Marijuana Rescheduling Over Health Risks
politics26 days ago

Barr and Sabet Warn Against Marijuana Rescheduling Over Health Risks

Former Trump-era Attorney General William Barr and anti-legalization advocate Kevin Sabet publish a Washington Post op-ed arguing marijuana has horrific health risks, offers no proven medical value, and should not be rescheduled; the piece comes as the DEA weighs broader rescheduling amid testimony on medical benefits, even as a 2023 HHS analysis acknowledged some medical value. Opponents warn that rescheduling could unlock tax deductions under 280E and boost industry marketing, while lawsuits continue challenging the process.

Video Supports DEA Agent's Exoneration in Memphis Burger King Shooting
crime1 month ago

Video Supports DEA Agent's Exoneration in Memphis Burger King Shooting

A Tennessee prosecutor released surveillance video of a May DEA/Memphis Police arrest attempt at a Memphis Burger King in which employee Darrin Pigram was fatally shot. Shelby County DA Steve Mulroy declined to charge DEA Agent Levy Blandon, saying Pigram reached for a handgun and Blandon acted lawfully. The footage, released for transparency and lacking audio, shows the confrontation without body-worn camera footage; Tennessee law generally allows broad handgun carry, and the incident has spotlighted use-of-force questions surrounding gun violence.

Fourth fatality tied to Memphis anti-crime task force during DEA raid
politics1 month ago

Fourth fatality tied to Memphis anti-crime task force during DEA raid

A fourth person has been killed in connection with the Trump-initiated Memphis Safe Task Force during a DEA operation, with authorities saying the suspect at a Poplar Avenue motel pointed a handgun after commands and officers fired; the Tennessee Bureau of Investigation is investigating, and the earlier three deaths occurred within two months in relation to the task force.

DEA Targets Kratom's Potent Additive: Temporary Schedule I Plan for 7-OH
health1 month ago

DEA Targets Kratom's Potent Additive: Temporary Schedule I Plan for 7-OH

The DEA plans to temporarily place 7-OH, an opioid-like component of kratom, in Schedule I for two years (potentially extending to a third) for products above a certain threshold. Supporters say the move protects public health by curbing dependence and abuse, while critics question the science and warn it could hurt consumers who rely on kratom; the policy is framed as a win for the mainstream kratom industry amid political and lobbying dynamics.

DEA and FDA Push to Reschedule Marijuana, Emphasizing Medical Use and Lower Harms
policy1 month ago

DEA and FDA Push to Reschedule Marijuana, Emphasizing Medical Use and Lower Harms

Opening day of a cannabis rescheduling hearing features DEA and FDA arguing that marijuana has medical benefits and lower day-to-day harms than alcohol or opioids, supporting moving it from Schedule I to Schedule III. Testimony describes real-world pain management benefits and relatively mild withdrawal, while opponents criticize the analysis and allege shifting precedent. The process continues through July 15 amid lawsuits and broader regulatory implications, including tax guidance, workplace rules, and updates to related federal forms and enforcement.

New Mexico AG Sparks Criminal Probe into DEA's Fentanyl Handling
us-news2 months ago

New Mexico AG Sparks Criminal Probe into DEA's Fentanyl Handling

New Mexico Attorney General Raúl Torrez has opened a criminal probe into the DEA’s handling of fentanyl shipments, seeking to determine whether federal actions contributed to fentanyl reaching streets. Gov. Michelle Lujan Grisham welcomed the review, and the DOJ said it would partner with state and local leaders to confront the fentanyl crisis, a move that sparked outrage among some officials while drawing support from overdose-family advocates cautioning that enforcement remains essential.

AP findings spur NM governor to demand federal probe into DEA fentanyl handling
politics2 months ago

AP findings spur NM governor to demand federal probe into DEA fentanyl handling

AP’s investigation shows a DEA strategy that prioritized large drug-network seizures, with reports of fentanyl shipments going unseized in New Mexico, including a 2023 event surveilling 74,000 pills. New Mexico’s overdose deaths rose 21% last year. Gov. Michelle Lujan Grisham is calling for a federal investigation and accountability, arguing lives in the state were at risk. DEA whistleblower David Howell and Empower Oversight are urging Senate and DOJ oversight, while victims’ groups criticize the agency’s approach amid public-health warnings that 'one pill can kill.'

DEA Blocks Agency Witness Ahead of Marijuana Rescheduling Hearing
politics2 months ago

DEA Blocks Agency Witness Ahead of Marijuana Rescheduling Hearing

The DEA told SAM it will not identify Luli Akinfiresoye, a DEA pharmacologist, as a witness for SAM’s case in the upcoming hearing on moving marijuana from Schedule I to Schedule III, citing Touhy regulations and potential Privacy Act protections. SAM had sought to question the official about cannabis harms, but the DEA says any testimony would require a formal Touhy request and could be shielded. The hearing, overseen by Administrative Law Judge Derek Julis, runs June 29 to July 15 and has drawn complaints over access, including a push to livestream, which the judge previously barred; multiple lawsuits challenge the process as the government defends the scheduling move that could unlock federal benefits for state-legal cannabis businesses.

DEA Sets Ground Rules for Marijuana Scheduling Hearing This Month
politics2 months ago

DEA Sets Ground Rules for Marijuana Scheduling Hearing This Month

A DEA judge issued a 12-page order detailing the ground rules for a hearing on moving marijuana from Schedule I to Schedule III, set to run June 29–July 15 at a DEA facility in Arlington, VA. Only designated opponents of cannabis reform are invited to participate; reform supporters were not. Each party will have a 15-minute opening, may call up to two witnesses, and face limited cross-examination, with post-hearing briefs due later. The proceeding is separate from the Biden-era action on medical cannabis and, if rescheduling occurs, could affect federal taxes, gun forms, and other regulations amid ongoing lawsuits challenging the effort.

DEA Hearing on Marijuana Rescheduling Opens With Opponents-Only Invitations
politics2 months ago

DEA Hearing on Marijuana Rescheduling Opens With Opponents-Only Invitations

DEA’s hearing on moving marijuana from Schedule I to Schedule III will run June 29–July 15, but invitees are limited to opponents of rescheduling, excluding supporters. The proceedings come amid multiple lawsuits and could unlock federal tax deductions, update gun-purchase forms, and expand protections for state-licensed medical cannabis if the rule is enacted.